BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 10097404)

  • 21. Recent advances in biomedical applications of accelerator mass spectrometry.
    Hah SS; Henderson PT; Turteltaub KW
    J Biomed Sci; 2009 Jun; 16(1):54. PubMed ID: 19534792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accelerator mass spectrometry at Arizona: geochronology of the climate record and connections with the ocean.
    Jull AJ; Burr GS; Beck JW; Donahue DJ; Biddulph D; Hatheway AL; Lange TE; McHargue LR
    J Environ Radioact; 2003; 69(1-2):3-19. PubMed ID: 12860086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accelerator mass spectrometry as a bioanalytical tool for nutritional research.
    Vogel JS; Turteltaub KW
    Adv Exp Med Biol; 1998; 445():397-410. PubMed ID: 9781403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A safer method for studying hormone metabolism in an Asian elephant (Elephas maximus): accelerator mass spectrometry.
    Yon L; Faulkner B; Kanchanapangka S; Chaiyabutr N; Meepan S; Lasley B
    Zoo Biol; 2010; 29(6):760-6. PubMed ID: 20127658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mass spectrometry and isotopes: a century of research and discussion.
    Budzikiewicz H; Grigsby RD
    Mass Spectrom Rev; 2006; 25(1):146-57. PubMed ID: 16134128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AMS method validation for quantitation in pharmacokinetic studies with concomitant extravascular and intravenous administration.
    Lappin G; Seymour M; Young G; Higton D; Hill HM
    Bioanalysis; 2011 Feb; 3(4):393-405. PubMed ID: 21338259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effective determination of the long-lived nuclide 41Ca in nuclear reactor bioshield concretes: comparison of liquid scintillation counting and accelerator mass spectrometry.
    Warwick PE; Croudace IW; Hillegonds DJ
    Anal Chem; 2009 Mar; 81(5):1901-6. PubMed ID: 19178149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of accelerator mass spectrometry for studies in nutrition.
    Jackson GS; Weaver C; Elmore D
    Nutr Res Rev; 2001 Dec; 14(2):317-34. PubMed ID: 19087429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accelerator mass spectrometry analyses of environmental radionuclides: sensitivity, precision and standardisation.
    Hotchkis M; Fink D; Tuniz C; Vogt S
    Appl Radiat Isot; 2000 Jul; 53(1-2):31-7. PubMed ID: 10879834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subattomole sensitivity in biological accelerator mass spectrometry.
    Salehpour M; Possnert G; Bryhni H
    Anal Chem; 2008 May; 80(10):3515-21. PubMed ID: 18422337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Big physics, small doses: the use of AMS and PET in human microdosing of development drugs.
    Lappin G; Garner RC
    Nat Rev Drug Discov; 2003 Mar; 2(3):233-40. PubMed ID: 12612650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroscience and accelerator mass spectrometry.
    Palmblad M; Buchholz BA; Hillegonds DJ; Vogel JS
    J Mass Spectrom; 2005 Feb; 40(2):154-9. PubMed ID: 15706618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrinsic erythrocyte labeling and attomole pharmacokinetic tracing of 14C-labeled folic acid with accelerator mass spectrometry.
    Buchholz BA; Arjomand A; Dueker SR; Schneider PD; Clifford AJ; Vogel JS
    Anal Biochem; 1999 May; 269(2):348-52. PubMed ID: 10222009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The synergy of elemental and biomolecular mass spectrometry: new analytical strategies in life sciences.
    Becker JS; Jakubowski N
    Chem Soc Rev; 2009 Jul; 38(7):1969-83. PubMed ID: 19551177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microdosing for early biokinetic studies in humans.
    Stenström K; Sydoff M; Mattsson S
    Radiat Prot Dosimetry; 2010; 139(1-3):348-52. PubMed ID: 20167793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FemtoMolar measurements using accelerator mass spectrometry.
    Salehpour M; Forsgard N; Possnert G
    Rapid Commun Mass Spectrom; 2009 Mar; 23(5):557-63. PubMed ID: 19177507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of accelerator mass spectrometry to macromolecules: preclinical pharmacokinetic studies on a polybisphosphonate.
    Salehpour M; Håkansson K; Höglund U; Grahn-Westin A; Nilsson S; Márquez M; Possnert G; Holmberg AR
    Rapid Commun Mass Spectrom; 2011 Sep; 25(17):2453-8. PubMed ID: 21818805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of the tissue distribution and excretion by accelerator mass spectrometry of the nonadecapeptide 14C-Moli1901 in beagle dogs after intratracheal instillation.
    Rickert DE; Dingley K; Ubick E; Dix KJ; Molina L
    Chem Biol Interact; 2005 Jun; 155(1-2):55-61. PubMed ID: 15893299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural intramolecular isotope measurements in physiology: elements of the case for an effort toward high-precision position-specific isotope analysis.
    Brenna JT
    Rapid Commun Mass Spectrom; 2001; 15(15):1252-62. PubMed ID: 11466780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.